The Swedish version of the Motivation and Pleasure Scale self-report (MAP-SR): psychometric properties in patients with schizophrenia or depression

References

• Pelizza L, Ferrari A. Anhedonia in schizophrenia and major depression: state or trait? Ann Gen Psychiatry. 2009;8(1):22. doi:10.1186/1744-859x-8-22.
   PubMedGoogle Scholar
• Leucht S, Tardy M, Komossa K, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379(9831):2063–2071. doi:10.1016/S0140-6736(12)60239-6.
   PubMed Web of Science ®Google Scholar
• Fusar-Poli P, Papanastasiou E, Stahl D, et al. Treatments of negative symptoms in schizophrenia: meta-Analysis of 168 randomized placebo-controlled trials. Schizophr Bull. 2015;41(4):892–899. doi:10.1093/schbul/sbu170.
   PubMed Web of Science ®Google Scholar
• Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev. 2011;35(3):537–555. doi:10.1016/j.neubiorev.2010.06.006.
   PubMed Web of Science ®Google Scholar
• Rizvi SJ, Pizzagalli DA, Sproule BA, et al. Assessing anhedonia in depression: potentials and pitfalls. Neurosci Biobehav Rev. 2016;65:21–35. doi:10.1016/j.neubiorev.2016.03.004.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Fenton WS, Carpenter WT, Jr, et al. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32(2):214–219. doi:10.1093/schbul/sbj053.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Strauss GP, Nguyen L, et al. The brief negative symptom scale: psychometric properties. Schizophr Bull. 2011;37(2):300–305. doi:10.1093/schbul/sbq059.
   PubMed Web of Science ®Google Scholar
• Blanchard JJ, Kring AM, Horan WP, et al. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr Bull. 2011;37(2):291–299. doi:10.1093/schbul/sbq104.
   PubMed Web of Science ®Google Scholar
• Forbes C, Blanchard JJ, Bennett M, et al. Initial development and preliminary validation of a new negative symptom measure: the clinical assessment interview for negative symptoms (CAINS). Schizophr Res. 2010;124(1-3):36–42. doi:10.1016/j.schres.2010.08.039.
   PubMed Web of Science ®Google Scholar
• Horan WP, Kring AM, Gur RE, et al. Development and psychometric validation of the clinical assessment interview for negative symptoms (CAINS). Schizophr Res. 2011;132(2-3):140–145. doi:10.1016/j.schres.2011.06.030.
   PubMed Web of Science ®Google Scholar
• Kring AM, Gur RE, Blanchard JJ, et al. The clinical assessment interview for negative symptoms (CAINS): final development and validation. Am J Psychiatry. 2013;170(2):165–172. doi:10.1176/appi.ajp.2012.12010109.
   PubMed Web of Science ®Google Scholar
• Engel M, Fritzsche A, Lincoln TM. Validation of the German version of the clinical assessment interview for negative symptoms (CAINS). Psychiatry Res. 2014;220(1-2):659–663. doi:10.1016/j.psychres.2014.07.070.
   PubMed Web of Science ®Google Scholar
• Chan RCK, Shi C, Lui SSY, et al. Validation of the Chinese version of the clinical assessment interview for negative symptoms (CAINS): a preliminary report. Front Psychol. 2015;6:7. doi:10.3389/fpsyg.2015.00007.
   PubMed Web of Science ®Google Scholar
• Valiente-Gómez A, Mezquida G, Romaguera A, et al. Validation of the Spanish version of the clinical assessment for negative symptoms (CAINS). Schizophr Res. 2015;166(1-3):104–109. doi:10.1016/j.schres.2015.06.006.
   PubMed Web of Science ®Google Scholar
• Jung SI, Woo J, Kim Y-T, et al. Validation of the Korean-version of the clinical assessment interview for negative symptoms of schizophrenia (CAINS). J Korean Med Sci. 2016;31(7):1114–1120. doi:10.3346/jkms.2016.31.7.1114.
   PubMed Web of Science ®Google Scholar
• Bengtsson J, Bodén R, Neider D, et al. A blinded validation of the Swedish version of the clinical assessment interview for negative symptoms (CAINS). Nord J Psychiatry. 2021;76(1):44–51. doi:10.1080/08039488.2021.1933174.
   PubMed Web of Science ®Google Scholar
• Park SG, Llerena K, McCarthy JM, et al. Screening for negative symptoms: preliminary results from the self-report version of the clinical assessment interview for negative symptoms. Schizophr Res. 2012;135(1-3):139–143. doi:10.1016/j.schres.2011.12.007.
   PubMed Web of Science ®Google Scholar
• Llerena K, Park SG, McCarthy JM, et al. The motivation and pleasure scale–self-report (MAP-SR): reliability and validity of a self-report measure of negative symptoms. Compr Psychiatry. 2013;54(5):568–574. doi:10.1016/j.comppsych.2012.12.001.
   PubMed Web of Science ®Google Scholar
• García-Portilla MP, García Álvarez L, Dal Santo F, et al. Spanish validation of the MAP-SR: two heads better than one for the assessment of negative symptoms of schizophrenia. Psicothema. 2021;33(3):473–480.
   PubMed Web of Science ®Google Scholar
• Wang L-L, Ma EPY, Lui SSY, et al. Validation and extension of the motivation and pleasure scale-self report (MAP-SR) across the schizophrenia spectrum in the chinese context. Asian J Psychiatr. 2020;49:101971. doi:10.1016/j.ajp.2020.101971.
   PubMed Web of Science ®Google Scholar
• Engel M, Lincoln TM. Motivation and pleasure scale-self-report (MAP-SR): validation of the German version of a self-report measure for screening negative symptoms in schizophrenia. Compr Psychiatry. 2016;65:110–115. doi:10.1016/j.comppsych.2015.11.001.
   PubMed Web of Science ®Google Scholar
• Dollfus S, Mach C, Morello R. Self-evaluation of negative symptoms: a novel tool to assess negative symptoms. Schizophr Bull. 2016;42(3):571–578. doi:10.1093/schbul/sbv161.
   PubMed Web of Science ®Google Scholar
• Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160(1):4–12. doi:10.1176/appi.ajp.160.1.4.
   PubMed Web of Science ®Google Scholar
• Richter J, Hölz L, Hesse K, et al. Measurement of negative and depressive symptoms: discriminatory relevance of affect and expression. Eur Psychiatry. 2019;55:23–28. doi:10.1016/j.eurpsy.2018.09.008.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International neuropsychiatric interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20(20):22–33.
   PubMedGoogle Scholar
• Bodén R, Bengtsson J, Thörnblom E, et al. Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression – a randomized controlled trial. J Affect Disord. 2021;290:308–315. doi:10.1016/j.jad.2021.04.053.
   PubMed Web of Science ®Google Scholar
• Shafer A, Dazzi F, Ventura J. Factor structure of the brief psychiatric rating scale – expanded (BPRS-E) in a large hospitalized sample. J Psychiatr Res. 2017;93:79–86. doi:10.1016/j.jpsychires.2017.05.011.
   PubMed Web of Science ®Google Scholar
• Svanborg P, Asberg M. A comparison between the beck depression inventory (BDI) and the self-rating version of the montgomery åsberg depression rating scale (MADRS). J Affect Disord. 2001;64(2-3):203–216. doi:10.1016/s0165-0327(00)00242-1.
   PubMed Web of Science ®Google Scholar
• Burström K, Sun S, Gerdtham UG, et al. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23(2):431–442. doi:10.1007/s11136-013-0496-4.
   PubMed Web of Science ®Google Scholar
• Guy W. ECDEU assessment manual. In PsycEXTRA Dataset. 1976. doi:10.1037/e591322011-001.
   Google Scholar
• Chouinard G, Margolese HC. Manual for the extrapyramidal symptom rating scale (ESRS). Schizophr Res. 2005;76(2-3):247–265. doi:10.1016/j.schres.2005.02.013.
   PubMed Web of Science ®Google Scholar
• Horberg N, Kouros I, Ekselius L, et al. The Swedish version of the Sheehan disability scale-a valid and brief measure of functioning. EJPCH. 2016;4(1):208–214. doi:10.5750/ejpch.v4i1.1075.
   Google Scholar
• Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol. 1999;14(2):167–177. doi:10.1093/arclin/14.2.167.
   PubMed Web of Science ®Google Scholar
• Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007;64(5):532–542. doi:10.1001/archpsyc.64.5.532.
   PubMed Web of Science ®Google Scholar
• Cohen J. A power primer. Psychol Bull. 1992;112(1):155–159. doi:10.1037/0033-2909.112.1.155.
   PubMed Web of Science ®Google Scholar
• Gardner DM, Murphy AL, O’Donnell H, et al. International consensus study of antipsychotic dosing. AJP. 2010;167(6):686–693. doi:10.1176/appi.ajp.2009.09060802.
   Google Scholar
• Mallet J, Guessoum SB, Tebeka S, et al. Self-evaluation of negative symptoms in adolescent and young adult first psychiatric episodes. Prog Neuropsychopharmacol Biol Psychiatry. 2020;103:109988. doi:10.1016/j.pnpbp.2020.109988.
   PubMed Web of Science ®Google Scholar
• Blanchard JJ, Bradshaw KR, Garcia CP, et al. Examining the reliability and validity of the clinical assessment interview for negative symptoms within the management of schizophrenia in clinical practice (MOSAIC) multisite national study. Schizophr Res. 2017;185:137–143. doi:10.1016/j.schres.2017.01.011.
   PubMed Web of Science ®Google Scholar
• Lambert C, Da Silva S, Ceniti AK, et al. Anhedonia in depression and schizophrenia: a transdiagnostic challenge. CNS Neurosci Ther. 2018;24(7):615–623. doi:10.1111/cns.12854.
   PubMed Web of Science ®Google Scholar